Compound Detail
CHEMBL282939
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
COc1cc([C@@H]2c3[nH]c4ccccc4c3C[C@H]3C(=O)NCC(=O)N23)cc(OC)c1O
Basic Information
| ChEMBL ID | CHEMBL282939 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | HTPGHTCBAMDAAS-MGPUTAFESA-N |
9
Targets
9
Activities
1
Assay Types
0
PK Parameters
13
Publications
0
Known Names
Molecular Properties
407.4
MW (Da)
1.86
ALogP
5
HBA
3
HBD
103.9
PSA (Ų)
0.61
QED
0
Ro5 Violations
3
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 9 meas. best 4.42
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Panel leukemia (Carcinoma cell lines) CHEMBL614083 | IC50 | 4.42 | 4.42 | 38018.9 | 1 |
| CNS cell CHEMBL614782 | IC50 | 4.42 | 4.42 | 38018.9 | 1 |
| Melanoma cell CHEMBL614126 | IC50 | 4.34 | 4.34 | 45708.8 | 1 |
| Colon cell CHEMBL614469 | IC50 | 4.33 | 4.33 | 46773.5 | 1 |
| Breast carcinoma cell CHEMBL614026 | IC50 | 4.31 | 4.31 | 48977.9 | 1 |
| Renal cell CHEMBL614738 | IC50 | 4.26 | 4.26 | 54954.1 | 1 |
| NSO CHEMBL615003 | IC50 | 4.25 | 4.25 | 56234.1 | 1 |
| Ovarian carcinoma cell CHEMBL614667 | IC50 | 4.18 | 4.18 | 66069.3 | 1 |
| Prostate cell CHEMBL614850 | IC50 | 4.15 | 4.15 | 70794.6 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Panel leukemia (Carcinoma cell lines) | IC50 | = | 38018.94 | nM | 4.42 | Inhibitory activity against leukemia cell line | 10780915 |
| CNS cell | IC50 | = | 38018.94 | nM | 4.42 | Inhibitory activity against CNS cell line | 10780915 |
| Melanoma cell | IC50 | = | 45708.82 | nM | 4.34 | Inhibitory activity against melanoma cell line | 10780915 |
| Colon cell | IC50 | = | 46773.51 | nM | 4.33 | Inhibitory activity against Colon cell line | 10780915 |
| Breast carcinoma cell | IC50 | = | 48977.88 | nM | 4.31 | Inhibitory activity against breast cell line | 10780915 |
| Renal cell | IC50 | = | 54954.09 | nM | 4.26 | Inhibitory activity against renal cell line | 10780915 |
| NSO | IC50 | = | 56234.13 | nM | 4.25 | Inhibitory activity against NSL cell line | 10780915 |
| Ovarian carcinoma cell | IC50 | = | 66069.34 | nM | 4.18 | Inhibitory activity against ovarian cell line | 10780915 |
| Prostate cell | IC50 | = | 70794.58 | nM | 4.15 | Inhibitory activity against prostate cell line | 10780915 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 10780915 | 10.1021/jm9905662 | 3Y1 cell line | 3 |
| 11392530 | 10.1016/s0960-894x(01)00136-6 | NCI-H520 | 3 |
| 11392530 | 10.1016/s0960-894x(01)00136-6 | PC-3 | 3 |
| 10780915 | 10.1021/jm9905662 | Panel leukemia (Carcinoma cell lines) | 1 |
| 10780915 | 10.1021/jm9905662 | NSO | 1 |
| 10780915 | 10.1021/jm9905662 | Colon cell | 1 |
| 10780915 | 10.1021/jm9905662 | CNS cell | 1 |
| 10780915 | 10.1021/jm9905662 | Melanoma cell | 1 |
| 10780915 | 10.1021/jm9905662 | Ovarian carcinoma cell | 1 |
| 10780915 | 10.1021/jm9905662 | Renal cell | 1 |
| 10780915 | 10.1021/jm9905662 | Prostate cell | 1 |
| 10780915 | 10.1021/jm9905662 | Breast carcinoma cell | 1 |
| 11392530 | 10.1016/s0960-894x(01)00136-6 | DNA topoisomerase II | 1 |
Data from ChEMBL 36 via Core Engine